Covered recipient · General Payments record
SANDRA A WEISS
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$3,953.79
- Reported across 258 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $560.57 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $184.63 | 21 |
| BOSTON SCIENTIFIC CORPORATION | $152.88 | 4 |
| PFIZER INC. | $91.65 | 4 |
| GlaxoSmithKline, LLC. | $49.44 | 3 |
| Medtronic, Inc. | $31.05 | 1 |
| Amgen Inc. | $22.06 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.76 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $6.41 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227541 | CMS |
| ABIOMED | $1.50 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227553 | CMS |
| ABIOMED | $6.41 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227515 | CMS |
| ABIOMED | $6.41 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227559 | CMS |
| ABIOMED | $6.36 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227561 | CMS |
| ABIOMED | $5.40 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227565 | CMS |
| ABIOMED | $6.41 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227581 | CMS |
| ABIOMED | $5.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227575 | CMS |
| ABIOMED | $6.41 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227595 | CMS |
| ABIOMED | $5.26 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227655 | CMS |
| ABIOMED | $5.26 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227653 | CMS |
| ABIOMED | $5.26 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227617 | CMS |
| ABIOMED | $5.26 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227621 | CMS |
| ABIOMED | $4.66 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227619 | CMS |
| ABIOMED | $40.19 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227625 | CMS |
| ABIOMED | $41.38 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227623 | CMS |
| ABIOMED | $5.26 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227639 | CMS |
| ABIOMED | $5.26 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227637 | CMS |
| ABIOMED | $5.26 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227641 | CMS |
| ABIOMED | $5.75 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227671 | CMS |
| ABIOMED | $5.26 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142227669 | CMS |
| Amgen Inc. | $22.06 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117715564 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.76 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118235105 | CMS |
| Boston Scientific Corporation | $105.90 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092328880 | CMS |
| Boston Scientific Corporation | $20.42 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092328878 | CMS |
| Boston Scientific Corporation | $14.03 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092328876 | CMS |
| Boston Scientific Corporation | $12.53 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092328874 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.10 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101756965 | CMS |
| GlaxoSmithKline, LLC. | $15.84 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116546551 | CMS |
| GlaxoSmithKline, LLC. | $17.57 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116408941 | CMS |
| GlaxoSmithKline, LLC. | $16.03 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115939979 | CMS |
| Medtronic, Inc. | $31.05 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119547343 | CMS |
| PFIZER INC. | $20.04 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130924599 | CMS |
| PFIZER INC. | $22.03 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130969166 | CMS |
| PFIZER INC. | $23.59 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130966510 | CMS |
| PFIZER INC. | $25.99 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131396480 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.